HLG Genomics Falls 4.65% on First Trading Day After Kosdaq IPO

According to Korea Exchange, HLG Genomics fell 4.65% to 20,500 won on its first day of trading on Kosdaq on July 24, falling below its offer price of 21,500 won. The active pharmaceutical ingredient manufacturer had surged to 25,500 won in early trading, but momentum reversed as institutional investors unloaded positions. Only 1.9% of participating institutional investors committed to long-term holdings, leaving 98.1% of the 1.345 billion shares held without lock-up pledges. The IPO raised 55.1 billion won for the company.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments